$AMBA

Young John Alexander sold $38K of AMBA

Young John Alexander (CFO) sold 400 shares of AMBARELLA INC (AMBA) at $96.00 on 2026-05-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Young John Alexander
Published May 29, 2026, 12:02 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 7:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMBA
Neutral
medium confidence
Mentioned
$AMBA
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBANeutralLow
01

Why it matters

The disclosure provides incremental sentiment information but does not introduce new company fundamentals or near-term catalysts.

02

Market read

Insider selling can be a minor negative read-through, but 10b5-1 plans generally limit interpretability.

03

What to watch

Traders may over-weight small Form 4 sales; the key is whether there are repeated sales, changes in total holdings, or concurrent company-specific news (not present here).

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed May 28 for a May 26 sale

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for AmbaRELLA, showing an officer sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$AMBANeutralMedium confidence
Context

AmbaRELLA CFO Young John Alexander sold 400 shares in an open-market transaction disclosed via SEC Form 4 on May 26 under a 10b5-1 plan.

Expected impact

Low likelihood of sustained price impact; any effect is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is an officer open-market sale and explicitly tied to a pre-arranged 10b5-1 plan, which typically reduces signal strength versus discretionary selling.

Market effects

Minimal; insider sale in a single semiconductor/AI vision name without accompanying operating or guidance changes.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • AMBARELLA INC

    Subject of the SEC Form 4 insider transaction; CFO sold shares under a 10b5-1 plan.

  • Young John Alexander

    CFO who executed the open-market sale disclosed in the filing.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMBAMedAI 8/10

Ambarella Q2 Earnings Call Highlights

Ambarella (AMBA) announced a $50M stock buyback program. Q3 revenue forecasted at $115M-$124M, with IoT demand driving growth. Memory constraints may impact customers. Raised 5-year market forecast to $22.9B. Partnered with Capgemini and Macnica for indirect sales. X7 AI accelerator sampling for edge infrastructure.

$AMBAHigh

AMBARELLA INC (AMBA): Results of Operations and Financial Condition

AMBARELLA INC (AMBA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ambarella, Inc. Announces Second Quarter Fiscal Year 2027 Financial Results September 3, 2026 —Santa Clara, Calif. – Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced second quarter fiscal 2027 financial results for the period ended Ju

$AMBAMedAI 8/10

Usain Bolt Just Got an AI Rival – Meet the Stocks Behind It

Unitree Robotics, a Chinese company, unveiled a humanoid robot 'Superman' claiming it runs faster than Usain Bolt. The company's IPO on the Shanghai Stock Exchange saw shares surge 460%, valuing it at $50 billion. Investors are betting on the humanoid robotics sector and its supply chain, including companies like Ambarella, Ouster, Cognex, Regal Rexnord, and Harmonic Drive Systems, which saw gains in July.